Search Results

影响Ⅲ 期食管癌术后患者预后的因素.

• Authors : 杨琼; 王玉祥; 何明

• Source: Chinese Journal of Oncology; 7/23/2016, Vol. 38 Issue 7, p530-537, 8p

Record details

[Predicting value of dynamic alteration of blood neutrophil/lymphocyte ratio on recurrence-free survival in patients with advanced colon cancer after operation and chemotherapy].

• Authors : Li J; The Third Department of General Surgery, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai 519000, China.; Jia YB

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Colonic Neoplasms/Colonic Neoplasms/Colonic Neoplasms/*therapy ; Lymphocytes/Lymphocytes/Lymphocytes/*immunology Folfox protocol

• Source: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery [Zhonghua Wei Chang Wai Ke Za Zhi] 2012 Nov; Vol. 15 (11), pp. 1171-4.Publisher: Zhongshan da xue Country of Publication: China NLM ID: 101177990 Publication Model: Print Cited Medium: Print ISSN: 1671-0274 (Print)

Record details

[Efficacy and safety of bevacizumab (BEV) plus chemotherapeutic agents in the treatment of metastatic colorectal cancer, mCRC].

• Authors : Guo X; Department of Oncology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.; Liu TS

Subjects: Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Colonic Neoplasms/Colonic Neoplasms/Colonic Neoplasms/*drug therapy Folfox protocol; IFL protocol; XELOX

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2013 Aug; Vol. 35 (8), pp. 604-7.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

[Role of pharmacokinetic monitoring of serum fluorouracil concentration in patients with local advanced and metastatic colorectal cancer and further improving efficacy of fluorouracil-based chemotherapy].

• Authors : Cai X; Department of Oncology, Shanghai First People's Hospital, Shanghai Jiaotong University, Shanghai 200080, China.; Xue P

Subjects: Adenocarcinoma*/Adenocarcinoma*/Adenocarcinoma*/blood ; Adenocarcinoma*/Adenocarcinoma*/Adenocarcinoma*/drug therapy ; Adenocarcinoma*/Adenocarcinoma*/Adenocarcinoma*/pathology Folfox protocol

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2012 Jan; Vol. 34 (1), pp. 39-43.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

[Advances in research on capecitabine as adjuvant treatment for colon cancer after radical resection].

• Authors : Zhang SZ

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Colonic Neoplasms/Colonic Neoplasms/Colonic Neoplasms/*drug therapy ; Deoxycytidine/Deoxycytidine/Deoxycytidine/*analogs & derivatives MOF protocol; XELOX

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2010 Nov; Vol. 32 (11), pp. 801-3.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

[Efficacy of cetuximab combined with chemotherapy for patients with advanced colorectal cancer and unclear K-ras status].

• Authors : Guo GF; State Key Laboratory of Oncology in South China, Guangzhou, China.; Xia LP

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*drug therapy ; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2010 Oct; Vol. 32 (10), pp. 777-81.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

[Clinical observation of XELOX (Capecitabine puls Oxaliplatin): an adjuvant chemotherapy regimen used in stage III colorectal cancer].

• Authors : Diao C; Department of General Surgery, The First Affiliated Hospital, Kunming Medical College, Kunming 650031, China.; Cheng RC

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Colonic Neoplasms/Colonic Neoplasms/Colonic Neoplasms/*drug therapy ; Rectal Neoplasms/Rectal Neoplasms/Rectal Neoplasms/*drug therapyFolfox protocol; XELOX

• Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2008 Feb; Vol. 30 (2), pp. 147-50.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

[Efficacy and toxicity of FOLFOX6 regimen in treating colorectal cancer patients with liver metastasis].

• Authors : Wang GQ; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.; Wan DS

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Colonic Neoplasms/Colonic Neoplasms/Colonic Neoplasms/*drug therapy ; Fluorouracil/Fluorouracil/Fluorouracil/*administration & dosage

• Source: Ai zheng = Aizheng = Chinese journal of cancer [Ai Zheng] 2007 Apr; Vol. 26 (4), pp. 411-4.Publisher: Zhongshan da xue zhong liu fang zhi zhong xin Country of Publication: China NLM ID: 9424852 Publication Model: Print Cited Medium: Print

Record details

[Prognostic analysis of 443 cases of stage II colorectal cancer and the value of adjuvant chemotherapy].

• Authors : Zhou ZG; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, PR China.; Pan ZZ

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Colonic Neoplasms/Colonic Neoplasms/Colonic Neoplasms/*drug therapy ; Rectal Neoplasms/Rectal Neoplasms/Rectal Neoplasms/*drug therapyFolfox protocol; XELOX

• Source: Ai zheng = Aizheng = Chinese journal of cancer [Ai Zheng] 2009 Sep; Vol. 28 (9), pp. 908-12.Publisher: Zhongshan da xue zhong liu fang zhi zhong xin Country of Publication: China NLM ID: 9424852 Publication Model: Print Cited Medium: Print

Record details

[Efficacy of FORFIRI regimen on oxaliplatin-based chemotherapy-failed advanced colorectal cancer].

• Authors : Li YH; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, PR China.; Wang FH

Subjects: Adenocarcinoma/Adenocarcinoma/Adenocarcinoma/*drug therapy ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Colonic Neoplasms/Colonic Neoplasms/Colonic Neoplasms/*drug therapy

• Source: Ai zheng = Aizheng = Chinese journal of cancer [Ai Zheng] 2009 Sep; Vol. 28 (9), pp. 913-8.Publisher: Zhongshan da xue zhong liu fang zhi zhong xin Country of Publication: China NLM ID: 9424852 Publication Model: Print Cited Medium: Print

Record details